References
- Donehower LA, Bradley A: The tumor suppressor p53. Biochim Biophys Acta 1993;1155(2):181-205
- Rowley H, Sherrington P, Helliwell TR, Kinsella A, Jones AS: p53 expression and p53 gene mutation in oral cancer and dysplasia. Otolaryngol Head Neck Surg 1998;118(1):115-123 https://doi.org/10.1016/S0194-5998(98)70387-0
- Kaelin WG Jr: The emerging p53 gene family. J Natl Cancer Inst 1999;91(7):594-598 https://doi.org/10.1093/jnci/91.7.594
- Choi HR, Batsakis JG, Zhan F, Sturgis E, Luna MA, El-Naggar AK: Differential expression of p53 gene family members p63 and p73 in head and neck squamous tumorigenesis. Hum Pathol 2002;33(2):158-164 https://doi.org/10.1053/hupa.2002.30722
- Di Como CJ, Urist MJ, Babayan I, Drobnjak M, Hedvat CV, Teruya-Feldstein J, et al: p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 2002;8(2):494-501
- Nylander K, Coates PJ, Hall PA: Characterization of the expression pattern of p63 alpha and delta Np63 alpha in benign and malignant oral epithelial lesions. Int J Cancer 2000;87(3):368-372 https://doi.org/10.1002/1097-0215(20000801)87:3<368::AID-IJC9>3.0.CO;2-J
- Urist MJ, Di Como CJ, Lu ML, Charytonowicz E, Verbel D, Crum CP, et al: Loss of p63 expression is associated with tumor progression in bladder cancer. Am J Pathol 2002;161(4):1199-1206 https://doi.org/10.1016/S0002-9440(10)64396-9
- Wu M, Wang B, Gil J, Sabo E, Miller L, Gan L, et al: p63 and TTF-1 immunostaining. A useful marker panel for distinguishing small cell carcinoma of lung from poorly differentiated squamous cell carcinoma of lung. Am J Clin Pathol 2003;119(5):696-702 https://doi.org/10.1309/P5ABR5KQ89RNJTFH
- Jost CA, Marin MC, Kaelin WG, Jr: p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature 1997;389(6647):191-194 https://doi.org/10.1038/38298
- Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A: p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 1999;398(6729):708-713 https://doi.org/10.1038/19531
- Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, et al: p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 1999;398(6729):714-718 https://doi.org/10.1038/19539
- Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S, et al: p63 identifies keratinocyte stem cells. Proc Natl Acad Sci U S A 2001;98(6):3156-3161
- Morris RJ, Coulter K, Tryson K, Steinberg SR: Evidence that cutaneous carcinogen-initiated epithelial cells from mice are quiescent rather than actively cycling. Cancer Res 1997;57(16):3436-3443
- Hagiwara K, McMenamin MG, Miura K, Harris CC: Mutational analysis of the p63/p73L/p51/p40/CUSP/KET gene in human cancer cell lines using intronic primers. Cancer Res 1999;59(17):4165-4169
- Osada M, Ohba M, Kawahara C, Ishioka C, Kanamaru R, Katoh I, et al: Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat Med 1998;4(7):839-843 https://doi.org/10.1038/nm0798-839
- Hibi K, Trink B, Patturajan M, Westra WH, Caballero OL, Hill DE, et al: AIS is an oncogene amplified in squamous cell carcinoma. Proc Natl Acad Sci U S A 2000;97(10):5462-5467
- Ikawa S, Nakagawara A, Ikawa Y: p53 family genes: structural comparison, expression and mutation. Cell Death Differ 1999;6(12):1154-1161 https://doi.org/10.1038/sj.cdd.4400631
- Nishi H, Isaka K, Sagawa Y, Usuda S, Fujito A, Ito H, et al: Mutation and transcription analyses of the p63 gene in cervical carcinoma. Int J Oncol 1999;15(6):1149-1153
- Parsa R, Yang A, McKeon F, Green H: Association of p63 with proliferative potential in normal and neoplastic human keratinocytes. J Invest Dermatol 1999;113(6):1099-1105 https://doi.org/10.1046/j.1523-1747.1999.00780.x
- Park BJ, Lee SJ, Kim JI, Lee CH, Chang SG, Park JH, et al: Frequent alteration of p63 expression in human primary bladder carcinomas. Cancer Res 2000;60(13):3370-3374
- Crook T, Nicholls JM, Brooks L, O'Nions J, Allday MJ: High level expression of deltaN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? Oncogene 2000;19(30):3439-3444 https://doi.org/10.1038/sj.onc.1203656
- Yamaguchi K, Wu L, Caballero OL, Hibi K, Trink B, Resto V, et al: Frequent gain of the p40/p51/p63 gene locus in primary head and neck squamous cell carcinoma. Int J Cancer 2000;86(5):684-689 https://doi.org/10.1002/(SICI)1097-0215(20000601)86:5<684::AID-IJC13>3.0.CO;2-M
- Polverini PJ, Nor JE: Apoptosis and predisposition to oral cancer. Crit Rev Oral Biol Med 1999;10(2):139-152 https://doi.org/10.1177/10454411990100020201
- Birchall MA, Winterford CM, Allan DJ, Harmon BV: Apoptosis in normal epithelium, premalignant and malignant lesions of the oropharynx and oral cavity: a preliminary study. Eur J Cancer B Oral Oncol 1995;31B(6):380-383
- Ravi D, Ramadas K, Mathew BS, Nalinakumari KR, Nair MK, Pillai MR: De novo programmed cell death in oral cancer. Histopathology 1999;34(3):241-249 https://doi.org/10.1046/j.1365-2559.1999.00575.x
- Birchall M, Winterford C, Tripconi L, Gobe G, Harmon B: Apoptosis and mitosis in oral and oropharyngeal epithelia: evidence for a topographical switch in premalignant lesions. Cell Prolif 1996;29(8):447-456 https://doi.org/10.1111/j.1365-2184.1996.tb00987.x
- Shklar G: Experimental oral pathology in the Syrian hamster. Prog Exp Tumor Res 1972;16:518-538
- Shklar G: Development of experimental oral carcinogenesis and its impact on current oral cancer research. J Dent Res 1999;78(12):1768-1772 https://doi.org/10.1177/00220345990780120101
- Gimenez-Conti IB, Shin DM, Bianchi AB, Roop DR, Hong WK, Conti CJ, et al: Changes in keratin expression during 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis. Cancer Res 1990;50(14):4441-4445
- Weber A, Bellmann U, Bootz F, Wittekind C, Tannapfel A: Expression of p53 and its homologues in primary and recurrent squamous cell carcinomas of the head and neck. Int J Cancer 2002;99(1):22-28 https://doi.org/10.1002/ijc.10296
- Chen YK, Hsue SS, Lin LM: Immunohistochemical demonstration of p63 in DMBA-induced hamster buccal pouch squamous cell carcinogenesis. Oral Dis 2003;9(5):235-240 https://doi.org/10.1034/j.1601-0825.2003.02920.x
- Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, et al: Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell 1997;90(4):809-819 https://doi.org/10.1016/S0092-8674(00)80540-1
- Schmale H, Bamberger C: A novel protein with strong homology to the tumor suppressor p53. Oncogene 1997;15(11):1363-1367 https://doi.org/10.1038/sj.onc.1201500
- Augustin M, Bamberger C, Paul D, Schmale H: Cloning and chromosomal mapping of the human p53-related KET gene to chromosome 3q27 and its murine homolog Ket to mouse chromosome 16. Mamm Genome 1998;9(11):899-902 https://doi.org/10.1007/s003359900891
- Trink B, Okami K, Wu L, Sriuranpong V, Jen J, Sidransky D: A new human p53 homologue. Nat Med 1998;4(7):747-748 https://doi.org/10.1038/nm0798-747
- Senoo M, Tsuchiya I, Matsumura Y, Mori T, Saito Y, Kato H, et al: Transcriptional dysregulation of the p73L / p63 / p51 / p40 / KET gene in human squamous cell carcinomas: expression of Delta Np73L, a novel dominant-negative isoform, and loss of expression of the potential tumour suppressor p51. Br J Cancer 2001;84(9):1235- 1241 https://doi.org/10.1054/bjoc.2000.1735
- Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, et al: p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998;2(3):305-316 https://doi.org/10.1016/S1097-2765(00)80275-0
- Little NA, Jochemsen AG: p63. Int J Biochem Cell Biol 2002;34(1):6-9 https://doi.org/10.1016/S1357-2725(01)00086-3
- Suliman Y, Opitz OG, Avadhani A, Burns TC, El-Deiry W, Wong DT, et al: p63 expression is associated with p53 loss in oralesophageal epithelia of p53-deficient mice. Cancer Res 2001;61(17):6467-6473
- Ratovitski EA, Patturajan M, Hibi K, Trink B, Yamaguchi K, Sidransky D: p53 associates with and targets Delta Np63 into a protein degradation pathway. Proc Natl Acad Sci USA 2001;98(4):1817-1822
- Signoretti S, Waltregny D, Dilks J, Isaac B, Lin D, Garraway L, et al: p63 is a prostate basal cell marker and is required for prostate development. Am J Pathol 2000;157(6):1769-1775 https://doi.org/10.1016/S0002-9440(10)64814-6
- Glickman JN, Yang A, Shahsafaei A, McKeon F, Odze RD: Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders. Hum Pathol 2001;32(11):1157-1165 https://doi.org/10.1053/hupa.2001.28951
- Sniezek JC, Matheny KE, Burkey BB, Netterville JL, Pietenpol JA: Expression of p63 and 14-3-3sigma in normal and hyperdifferentiated mucosa of the upper aerodigestive tract. Otolaryngol Head Neck Surg 2002;126(6):598-601 https://doi.org/10.1067/mhn.2002.125302
- Wang TY, Chen BF, Yang YC, Chen H, Wang Y, Cviko A, et al: Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases. Hum Pathol 2001;32(5):479-486 https://doi.org/10.1053/hupa.2001.24324
- Sumida T, Hamakawa H, Sogawa K, Bao Y, Zen H, Sugita A, et al: Telomerase activation and cell proliferation during 7,12-dimethylbenz[a]anthracene-induced hamster cheek pouch carcinogenesis. Mol Carcinog 1999;25(3):164-168 https://doi.org/10.1002/(SICI)1098-2744(199907)25:3<164::AID-MC2>3.0.CO;2-5
- Wang JL, Zheng BY, Li XD, Angstrom T, Lindstrom MS, Wallin KL: Predictive significance of the alterations of p16INK4A, p14ARF, p53, and proliferating cell nuclear antigen expression in the progression of cervical cancer. Clin Cancer Res 2004;10(7):2407-2414 https://doi.org/10.1158/1078-0432.CCR-03-0242
- Todd R, Chou MY, Matossian K, Gallagher GT, Donoff RB, Wong DT: Cellular sources of transforming growth factor-alpha in human oral cancer. J Dent Res 1991;70(5):917-923 https://doi.org/10.1177/00220345910700051101
- Birchall MA, Schock E, Harmon BV, Gobe G: Apoptosis, mitosis, PCNA and bcl-2 in normal, leukoplakic and malignant epithelia of the human oral cavity: prospective, in vivo study. Oral Oncol 1997;33(6):419-425 https://doi.org/10.1016/S0964-1955(97)00033-X